ArticleJournal of the American Heart Association2013

P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activity.

Michelle A Berny-Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.